(Q39983230)

16 September 2017

1 reference

title

The use of beta-adrenergic receptor blocking drugs in dysrhythmias (English)

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Cardiology and cardiovascular medicine

16 March 2023

main subject

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

16 March 2023

author name string

D. Gibson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4896961

16 March 2023

E. Sowton

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4896961

16 March 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4896961

16 March 2023

publication date

1 July 1969

1 reference

full work available at URL

16 September 2017

https://api.elsevier.com/content/article/PII:0033062069900334?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

https://api.elsevier.com/content/article/PII:0033062069900334?httpAccept=text/plain

16 March 2023

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Progress in Cardiovascular Diseases

16 March 2023

published in

1 reference

16 September 2017

volume

12

1 reference

16 September 2017

issue

1

1 reference

16 September 2017

page(s)

16-39

1 reference

The Physiological Effects of Extracts of the Suprarenal Capsules

16 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Influence of sympathomimetic pressor drugs on arrhythmias caused by multiple stimuli

16 March 2023

2

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Pharmacology of a new adrenergic beta-receptor-blocking compound (Nethalide)

16 March 2023

4

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

A NEW ADRENERGIC BETARECEPTOR ANTAGONIST

16 March 2023

5

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

THE PHYSIOLOGICAL BASIS OF CARDIAC ARRHYTHMIAS

16 March 2023

6

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Generation and conduction of impulses in the heart as affected by drugs

16 March 2023

7

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Electrophysiological study of human heart muscle

16 March 2023

8

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

NONUNIFORM RECOVERY OF EXCITABILITY IN VENTRICULAR MUSCLE

16 March 2023

9

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Effects of propranolol on the transmembrane potentials of ventricular muscle and Purkinje fibers of the dog.

16 March 2023

12

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Effects of propranolol and ouabain on the conducting system of the heart in dogs

16 March 2023

14

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Appraisal of the effects of catecholamines on cardiac electrical activity.

16 March 2023

15

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Mode of action of beta receptor antagonists on cardiac muscle

16 March 2023

16

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

SOME CELLULAR AND METABOLIC CONSIDERATIONS RELATING TO THE ACTION OF QUINIDINE AS A PROTOTYPE ANTIARRHYTHMIC AGENT

16 March 2023

17

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Electrophysiological effects of diphenylhydantoin on canine purkinje fibers

16 March 2023

18

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

The Interaction of Anesthetic Agents and Adrenergic Drugs to Produce Cardiac Arrhythmias

16 March 2023

19

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Optical Isomers of Propranolol

16 March 2023

20

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

The biological properties of the optical isomers of propranolol and their effects on cardiac arrhythmias

16 March 2023

22

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Selective blockade of adrenoceptive beta receptors in the heart

16 March 2023

24

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Antisympathomimetic and antifibrillatory effects of pronethalol and propranolol

16 March 2023

26

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Antiarrhythmic actions of propranolol in the dog heart-lung preparation

16 March 2023

27

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Effect of quinidine and pronethalol on acetylstrophanthidin-induced ventricular arrhythmia in cats treated with reserpine.

16 March 2023

28

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Post-countershock arrhythmias in untreated and digitalized dogs.

16 March 2023

29

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Effect of isoproterenol in digitalis cardiotoxicity

16 March 2023

30

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

A clinical study on the mechanism of the antiarrhythmic action of a new antagonist to β-adrenergic receptor

16 March 2023

33

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Clinical use of I.C.I. 50172 as an antidysrhythmic agent in heart failure

16 March 2023

34

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Effects of beta-adrenergic receptor blockade in normal subjects before, during, and after triiodothyronine-induced hypermetabolism

16 March 2023

39

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Specificity of beta-receptor antagonists

16 March 2023

40

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Inotropic and chronotropic effects of a series of beta-adrenergic blocking drugs: some structure-activity relationships

16 March 2023

44

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Effect of adrenergic receptor blockade of the tachycardia of thyrotoxicosis and anxiety state

16 March 2023

47

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Clinical experiences with propranolol

16 March 2023

50

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Use of a beta adrenergic receptor blocking agent (propranolol) in the treatment of cardiac arrhythmias

16 March 2023

52

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Beta-sympathetic blockade in hyperthyroidism

16 March 2023

53

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

A new beta-adrenergic receptor blocking agent, H 56/28, in the treatment of cardiac arrhythmias

16 March 2023

56

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Beta adrenergic blocking drugs in the clinical management of cardiac arrhythmias.

16 March 2023

58

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Immediate effects of intravenous propranolol on various cardiac arrhythmias.

16 March 2023

59

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Propranolol in management of muscular subaortic stenosis

16 March 2023

60

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Propranolol (Inderal) in cardiac arrhythmias

16 March 2023

63

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Beta-adrenergic blockade and cardiac arrhythmias

16 March 2023

67

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Treatment of cardiac arrhythmias in unanesthetized patients. Role of adrenergic beta receptor blockade.

16 March 2023

68

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Clinical observations on the use of propranolol in disorders of cardiac rhythm

16 March 2023

69

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Propranolol in cardiac arrhythmias

16 March 2023

70

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Propranolol in the Treatment and Prevention of Cardiac Arrhythmias

16 March 2023

71

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

EFFECTS OF BETA-ADRENERGIC BLOCKADE WITH PROPRANOLOL IN PATIENTS WITH ATRIAL ARRHYTHMIAS

16 March 2023

72

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Life-threatening disorders of the heart rhythm and beta receptor blocking agents

16 March 2023

80

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Treatment of cardiac arrhythmias with beta-adrenergic blocking agents. Clinical and experimental studies.

16 March 2023

82

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Acute and chronic effects of an adrenergic beta-receptor blocking agent (propranolol) in treatment of cardiac arrhythmias

16 March 2023

83

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

The anti-arrhythmic effect of propranolol

16 March 2023

84

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

PROPRANOLOL (INDERAL) IN DISTURBANCES OF CARDIAC RHYTHM

16 March 2023

85

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Propranolol in the treatment of digitalis-induced and digitalis-resistant tachycardias

16 March 2023

86

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Clinical experiences with beta-adrenergic blocking agents

16 March 2023

87

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

The antiarrhythmic effects of propranolol

16 March 2023

90

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Haemodynamic effects of propranolol (Inderal) in acute myocardial infarction.

16 March 2023

91

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Cardio-circulatory effects of beta-adrenergic blockade in organic heart disease. Comparison between propranolol and CIBA 39,089-Ba

16 March 2023

94

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Conversion of atrial fibrillation and flutter by propranolol

16 March 2023

95

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Conversion of chronic atrial fibrillation to sinus rhythm with combined propranolol and quinidine treatment

16 March 2023

96

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Combined propranolol and quinidine treatment in cardiac arrhythmias

16 March 2023

97

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Cardiac failure in patients with valvar heart disease after use of propranolol to control atrial fibrillation

16 March 2023

100

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Long term treatment of paroxysmal cardiac arrhythmias with propranolol.

16 March 2023

103

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Atrial reciprocal rhythm and reciprocating tachycardia in Wolff-Parkinson-White syndrome.

16 March 2023

107

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Propranolol in paroxysmal ventricular tachycardia

16 March 2023

109

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Beta-adrenergic blockade in the treatment of exercise-induced paroxysmal ventricular tachycardia

16 March 2023

110

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Propranolol (inderal) in the long term prophylaxis of ventricular arrhythmias

16 March 2023

112

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Digitalis-induced arrhythmias and their management

16 March 2023

114

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Sensitivity to propranolol after digoxin intoxication

16 March 2023

115

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Pharmacological Studies with Tofrānil

16 March 2023

116

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

CARDIOVASCULAR EFFECTS OF IMIPRAMINE

16 March 2023

117

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Survival after imipramine poisoning

16 March 2023

118

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Quinidine-induced Paroxysmal Ventricular Fibrillation Treated with Propranolol

16 March 2023

119

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Beta-adrenergic blockade in cardiac infarction

16 March 2023

121

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Management of arrhythmias in acute myocardial infarction

16 March 2023

123

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Incidence and management of supraventricular arrhythmias after acute myocardial infarction

16 March 2023

124

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

PROPRANOLOL (INDERAL) IN PERSISTENT VENTRICULAR FIBRILLATION

16 March 2023

126

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Propranolol in persistent ventricular fibrillation complicating acute myocardial infarction

16 March 2023

128

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

PROPRANOLOL IN ATTEMPTED MAINTENANCE OF SINUS RHYTHM AFTER ELECTRICAL DEFIBRILLATION

16 March 2023

134

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Effects of Propranolol on Patients with Complete Heart Block and Implanted Pacemakers

16 March 2023

135

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Standby Pacing for Multiple Cardiac Arrhythmias

16 March 2023

137

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

THE SUPPRESSION OF ARRHYTHMIAS BY ARTIFICIAL PACEMAKING

16 March 2023

138

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Transvenous left atrial pacing for the control of recurrent ventricular fibrillation

16 March 2023

139

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

Recurrent ventricular tachycardia and fibrillation treated with a combination of beta-adrenergic blockade and electrical pacing

16 March 2023

140

1 reference

https://api.crossref.org/works/10.1016/0033-0620(69)90033-4

16 March 2023

Identifiers

1 reference

release_neboyjrfcbdi5g3gmj5wbltrwm

16 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/neboyjrfcbdi5g3gmj5wbltrwm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference